Showing results (51-60 of 473) with videos related to

Sort By:
Pageof 48
Hereditary Cancer in Clinical Practice|November 17, 2011
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from GreeceChrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, et al.
Hereditary Cancer in Clinical Practice|February 26, 2010
Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectivesAudrey Ardern-Jones, Regina Kenen, Elly Lynch, et al.
Hereditary Cancer in Clinical Practice|October 14, 2017
Emotional impact on the results of BRCA1 and BRCA2 genetic test: an observational retrospective studySara Mella, Barbara Muzzatti, Riccardo Dolcetti, et al.
Hereditary Cancer in Clinical Practice|August 25, 2015
Cumulative BRCA mutation analysis in the Greek population confirms that homogenous ethnic background facilitates genetic testingAlexandra Tsigginou, Fotios Vlachopoulos, Iordanis Arzimanoglou, et al.
Hereditary Cancer in Clinical Practice|August 25, 2015
Next-generation sequencing for genetic testing of familial colorectal cancer syndromesMichele Simbolo, Andrea Mafficini, Marco Agostini, et al.
Hereditary Cancer in Clinical Practice|January 9, 2018
Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratorySabrina A Gardner, Katelyn S Weymouth, Wei S Kelly, et al.
Hereditary Cancer in Clinical Practice|January 18, 2018
BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in NorwayCecilie Heramb, Teresia Wangensteen, Eli Marie Grindedal, et al.
Hereditary Cancer in Clinical Practice|January 18, 2019
Validation of a digital identification tool for individuals at risk for hereditary cancer syndromesLeslie Bucheit, Katherine Johansen Taber, Kaylene Ready
Hereditary Cancer in Clinical Practice|August 27, 2009
Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrumRein P Stulp, Johanna C Herkert, Arend Karrenbeld, et al.
Pageof 48